Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Deadline For CFC Inhalers Looms, Firms Offer Incentives For HFA Switch

Executive Summary

By the end of the year, metered dose inhalers containing chlorofluorocarbon (CFC) propellants will no longer be on the market. While consumers with asthma or chronic bronchitis will have no choice but to switch to alternative hydrofluoroalkane (HFA)-propelled products, many have been reluctant to do so
Advertisement

Related Content

No Relief In Sight For Future Of OTC Asthma Products
No Relief In Sight For Future Of OTC Asthma Products
Teva winning the albuterol wars
Teva winning the albuterol wars
Consumers Complain To FDA About Albuterol Inhalers, Oxycontin Abuse
Consumers Complain To FDA About Albuterol Inhalers, Oxycontin Abuse
FDA Proposes Elimination of Seven Metered-Dose Inhaler Compounds
FDA Proposes Elimination of Seven Metered-Dose Inhaler Compounds
Advertisement
UsernamePublicRestriction

Register

PS049711

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel